KCNQ2/KCNQ3 channel openers (AbbVie)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameKCNQ2/KCNQ3 channel openers (AbbVie)
Drug Alias NameKCNQ2/KCNQ3 channel openers (Abbott)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium voltage-gated channel subfamily KQT member 3 stimulantsVoltage-gated potassium channel subunit Kv7.2 agonists
TargetsVoltage-gated potassium channel subunit Kv7.2Potassium voltage-gated channel subfamily KQT member 3
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott LaboratoriesAbbvie Inc
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A